Teva Pharmaceutical Industries (TEVA) Enterprise Value (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Enterprise Value came in at -$3.7 billion in Q2 2026, down 69.5% YoY from -$12.0 billion in Q2 2025, and up 2.3% on a QoQ basis from -$3.7 billion in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Enterprise Value (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Enterprise Value data on file, last reported at -$3.7 billion in Q2 2026.
- Quarterly Enterprise Value fell 69.5% year-over-year to -$3.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.7 billion (down 69.5% YoY) and the FY2025 annual result came in at -$3.6 billion, down 20.0% from the prior year.
- Enterprise Value improved to -$3.7 billion in Q2 2026, from -$3.7 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.3 billion in Q1 2022 to a low of -$3.7 billion in Q1 2026.
- A 5-year average of -$2.3 billion and a median of -$2.1 billion in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value jumped 38.0% — and 2026, when it plunged 121.12%.
- Tracing TEVA's Enterprise Value over 5 years: stood at -$2.0 billion in 2022, then decreased by 29.85% to -$2.6 billion in 2023, then declined by 13.58% to -$3.0 billion in 2024, then slipped by 20.0% to -$3.6 billion in 2025, then declined by 2.79% to -$3.7 billion in 2026.
- The last three Enterprise Value figures came in at -$3.7 billion (Q2 2026), -$3.7 billion (Q1 2026), and -$3.6 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.65 Bn |
| Mar 31, 2026 | -3.74 Bn |
| Dec 31, 2025 | -3.55 Bn |
| Sep 30, 2025 | -2.20 Bn |
| Jun 30, 2025 | -2.15 Bn |
| Mar 31, 2025 | -1.69 Bn |
| Dec 31, 2024 | -2.96 Bn |
| Sep 30, 2024 | -3.00 Bn |
| Jun 30, 2024 | -2.05 Bn |
| Mar 31, 2024 | -2.73 Bn |
| Dec 31, 2023 | -2.61 Bn |
| Sep 30, 2023 | -1.67 Bn |
| Jun 30, 2023 | -2.01 Bn |
| Mar 31, 2023 | -1.39 Bn |
| Dec 31, 2022 | -2.01 Bn |
| Sep 30, 2022 | -1.47 Bn |
| Jun 30, 2022 | -1.27 Bn |
| Mar 31, 2022 | -1.26 Bn |
| Dec 31, 2021 | -1.20 Bn |
| Sep 30, 2021 | -1.06 Bn |